Renal replacement is a procedure which involves the exchange of affected blood-filtering functioning of the kidneys which can be caused by kidney injuries and kidney disease. Renal replacement therapy can be classified into peritoneal dialysis, intermittent hemodialysis, and continuous renal replacement therapy. Continuous renal replacement therapy is given to the patients suffering from acute kidney injury especially for hemodynamically unstable cases. Continuous renal replacement includes hemodialysis, hemofiltration or a combination of both. It differs from the conventional renal replacement therapies whereas intermittent hemodialysis last for six hours and continuous renal replacement therapy lasts for 24 hours. Continuous renal therapy include removal of fluid or solute at the slower rate per unit time, hence continuous renal replacement therapy is widely adopted over conventional therapies.
Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/1051
Growing incidence of chronic kidney disease to foster the market growth of continuous renal replacement therapy market
Rising incidence of kidney disease which may lead to diabetes, cardiovascular disease, and inflammatory disease of the kidney called glomerulonephritis. According to National Center for Biotechnology Information (NCBI) in 2014, around 200 million people were diagnosed with chronic kidney disease, which may lead to the complete loss of renal failure or kidney injury and can also result in end-stage renal disease if left untreated. Hence, this requires continuous renal replacement therapy. The growing number of acute kidney injury cases and the advent of technological advancement in the field of pediatric, such as Cardio-Renal Pediatric Dialysis Emergency Machine (CARPEDIUM) for the treatment of acute kidney injury in kids and children are some of the other major factor propelling the market growth. On the other hand, reimbursement, high complexity of the procedure and high cost of the procedure are projected to hamper the market growth.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 25% OFF On Any Research Report
Apply Promo Code “CHRISTMAS2020” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1051
Market Taxonomy
Continuous renal replacement therapy market can be segmented based on the product, modality, end-user, and geography.
By Product
- Dialysate And Replacement Fluids
- Disposables
- Bloodline Sets
- Hemofilters Systems
By modality
- Slow Continuous Ultrafiltration
- Continuous Venovenous Hemofiltration
- Continuous Venovenous Hemodialysis
- Continuous Venovenous Hemodiafiltration
By end-user
- Hospitals
- Dialysis Clinics
- Others
Based on geography, continuous renal replacement therapy market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to dominate the global continuous renal replacement therapy market, and this can be attributed to the rising incidences of chronic kidney disease. According to American Kidney Fund, in 2015, around 31 million people were diagnosed with chronic kidney disease and it is the ninth leading cause of death in the U.S. Moreover, an innovative technology called wearable artificial kidney launched in the U.S, in 2015 has been designed to provide continuous renal replacement 24 hours a day thus providing feasibility and affordability to the patients.
At the same time, Asia Pacific is projected to show a promising region for continuous renal replacement therapy market over the forecast timeline owing to the growing investment for improving healthcare infrastructure and the presence of large patients suffering from chronic disease.
To get detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/1051
Innovative Multifiltrate PRO launched by Fresenius Medical care AG &Co. KGaA to foster the growth of continuous renal replacement therapy market
The key players in the continuous renal replacement therapy market are Baxter International, Nikkiso Co. Ltd., B. Braun Melsungen AG, Bellco S.r.I, NxStage Medical, Asahi Kasei Corporation, Medica S.P.A, Toray Medical Co., Nipro Corporation, Medtronic Plc, and Dialysis Solutions Inc. The key players are focusing on strategic mergers and acquisition and development of innovative therapy systems. For instance, Fresenius Medical Care AG & Co. KGaA, in May 2015, launched a new therapy system named Multifiltrate PRO for continuous renal replacement therapy and also for the acute kidney failure.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837